Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-03
DOI
10.3389/fpsyt.2021.780975
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature
- (2021) Giovanni Martinotti et al. Brain Sciences
- Vascular endothelial growth factor and pigment epithelial-derived factor in the peripheral response to ketamine
- (2020) Claire L. McGrory et al. JOURNAL OF AFFECTIVE DISORDERS
- Comparative Effectiveness of Esketamine in the Treatment of Anhedonia in Bipolar and Unipolar Depression
- (2020) Rodrigo Simonini Delfino et al. JOURNAL OF AFFECTIVE DISORDERS
- Treatment of depression with ketamine does not change plasma levels of brain-derived neurotrophic factor or vascular endothelial growth factor
- (2020) Gustavo C. Medeiros et al. JOURNAL OF AFFECTIVE DISORDERS
- Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine
- (2019) Satoshi Deyama et al. AMERICAN JOURNAL OF PSYCHIATRY
- Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review
- (2019) Bing Cao et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials
- (2019) Katrina Witt et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Ketamine-induced changes in plasma brain-derived neurotrophic factor (BDNF) levels are associated with the resting-state functional connectivity of the prefrontal cortex
- (2019) Marie Woelfer et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
- (2018) Samuel T. Wilkinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
- (2018) Marion J. F. Levy et al. PSYCHOPHARMACOLOGY
- Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression
- (2018) Wei Zheng et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Neurotrophic and Antidepressant Actions of Brain-Derived Neurotrophic Factor Require Vascular Endothelial Growth Factor
- (2018) Satoshi Deyama et al. BIOLOGICAL PSYCHIATRY
- Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder
- (2018) Wei Zheng et al. JOURNAL OF AFFECTIVE DISORDERS
- Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials
- (2017) Elizabeth D. Ballard et al. JOURNAL OF AFFECTIVE DISORDERS
- Hippocampal VEGF is necessary for antidepressant-like behaviors but not sufficient for antidepressant-like effects of ketamine in rats
- (2016) Miyeon Choi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Anhedonia and general distress show dissociable ventromedial prefrontal cortex connectivity in major depressive disorder
- (2016) C B Young et al. Translational Psychiatry
- Neural correlates of change in major depressive disorder anhedonia following open-label ketamine
- (2015) Níall Lally et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The role of neurotrophins in bipolar disorder
- (2015) Gustavo Scola et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Anhedonia predicts suicidal ideation in a large psychiatric inpatient sample
- (2014) E. Samuel Winer et al. PSYCHIATRY RESEARCH
- Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression
- (2014) N Lally et al. Translational Psychiatry
- Dimensions in major depressive disorder and their relevance for treatment outcome
- (2013) Elske Vrieze et al. JOURNAL OF AFFECTIVE DISORDERS
- Acute Increases in Plasma Mammalian Target of Rapamycin, Glycogen Synthase Kinase-3β, and Eukaryotic Elongation Factor 2 Phosphorylation After Ketamine Treatment in Three Depressed Patients
- (2012) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- Monitoring Ketamine Treatment Response in a Depressed Patient via Peripheral Mammalian Target of Rapamycin Activation
- (2011) Magdalena C. Denk et al. AMERICAN JOURNAL OF PSYCHIATRY
- VEGF regulates antidepressant effects of lamotrigine
- (2011) Rongju Sun et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Chronic ketamine use increases serum levels of brain-derived neurotrophic factor
- (2010) Valerio Ricci et al. PSYCHOPHARMACOLOGY
- Vascular Endothelial Growth Factor Signaling is Required for the Behavioral Actions of Antidepressant Treatment: Pharmacological and Cellular Characterization
- (2009) Joshua Greene et al. NEUROPSYCHOPHARMACOLOGY
- Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder
- (2009) Shih-Jen Tsai et al. PSYCHIATRY RESEARCH
- Neural representation of reward in recovered depressed patients
- (2009) Ciara McCabe et al. PSYCHOPHARMACOLOGY
- VEGF as a potential target for therapeutic intervention in depression
- (2007) J WARNERSCHMIDT et al. CURRENT OPINION IN PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search